Gan-Lu-Yin inhibits proliferation and migration of murine WEHI-3 leukemia cells and tumor growth in BALB/C allograft tumor model

Fon Chang Liu, Chun Hsu Pan, Ming Tsung Lai, Shu Jen Chang, Jing Gung Chung, Chieh Hsi Wu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The aim of this study was to explore the antitumor effect of Gan-Lu-Yin (GLY), a traditional Chinese herbal formula, on leukemia. Ethanolic extract of GLY was applied to evaluate its regulatory mechanisms in proliferation, migration, and differentiation of WEHI-3 leukemic cells as well as antitumor effect on BALB/c mice model. The results showed that GLY markedly reduced cell proliferation and migration with induced differentiation of WEHI-3 cells. The expression level of phosphorylated FAK, Akt, ERK1/2, and Rb was decreased p21 expression while level was increased in WEHI-3 treated with GLY. The results of cell cycle analysis revealed that GLY treatment could markedly induce G1 phase arrest and decrease cell population in S phase. Moreover, experimental results demonstrated that GLY decreased the protein expression and enzyme activity of MMP-2 and MMP-9. GLY treatment also reduced WEHI-3 leukemic infiltration in liver and spleen and tumor growth in animal model. Accordingly, GLY demonstrated an inhibitory effect on tumor growth with a regulatory mechanism partially through inhibiting FAK, Akt, and ERK expression in WEHI-3 cells. GLY may provide a promising antileukemic approach in the clinical application.

Original languageEnglish
Article number684071
JournalEvidence-based Complementary and Alternative Medicine
Volume2013
DOIs
Publication statusPublished - 2013
Externally publishedYes

Fingerprint

Allografts
Leukemia
Growth
Matrix Metalloproteinases
Neoplasms
Leukemic Infiltration
G1 Phase
Population Dynamics
S Phase
Cell Movement
Cell Cycle
Spleen
Animal Models
Cell Proliferation
Liver
Enzymes
Proteins

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

Gan-Lu-Yin inhibits proliferation and migration of murine WEHI-3 leukemia cells and tumor growth in BALB/C allograft tumor model. / Liu, Fon Chang; Pan, Chun Hsu; Lai, Ming Tsung; Chang, Shu Jen; Chung, Jing Gung; Wu, Chieh Hsi.

In: Evidence-based Complementary and Alternative Medicine, Vol. 2013, 684071, 2013.

Research output: Contribution to journalArticle

@article{db2b7e63175248e39d13dc5128d31eba,
title = "Gan-Lu-Yin inhibits proliferation and migration of murine WEHI-3 leukemia cells and tumor growth in BALB/C allograft tumor model",
abstract = "The aim of this study was to explore the antitumor effect of Gan-Lu-Yin (GLY), a traditional Chinese herbal formula, on leukemia. Ethanolic extract of GLY was applied to evaluate its regulatory mechanisms in proliferation, migration, and differentiation of WEHI-3 leukemic cells as well as antitumor effect on BALB/c mice model. The results showed that GLY markedly reduced cell proliferation and migration with induced differentiation of WEHI-3 cells. The expression level of phosphorylated FAK, Akt, ERK1/2, and Rb was decreased p21 expression while level was increased in WEHI-3 treated with GLY. The results of cell cycle analysis revealed that GLY treatment could markedly induce G1 phase arrest and decrease cell population in S phase. Moreover, experimental results demonstrated that GLY decreased the protein expression and enzyme activity of MMP-2 and MMP-9. GLY treatment also reduced WEHI-3 leukemic infiltration in liver and spleen and tumor growth in animal model. Accordingly, GLY demonstrated an inhibitory effect on tumor growth with a regulatory mechanism partially through inhibiting FAK, Akt, and ERK expression in WEHI-3 cells. GLY may provide a promising antileukemic approach in the clinical application.",
author = "Liu, {Fon Chang} and Pan, {Chun Hsu} and Lai, {Ming Tsung} and Chang, {Shu Jen} and Chung, {Jing Gung} and Wu, {Chieh Hsi}",
year = "2013",
doi = "10.1155/2013/684071",
language = "English",
volume = "2013",
journal = "Evidence-based Complementary and Alternative Medicine",
issn = "1741-427X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Gan-Lu-Yin inhibits proliferation and migration of murine WEHI-3 leukemia cells and tumor growth in BALB/C allograft tumor model

AU - Liu, Fon Chang

AU - Pan, Chun Hsu

AU - Lai, Ming Tsung

AU - Chang, Shu Jen

AU - Chung, Jing Gung

AU - Wu, Chieh Hsi

PY - 2013

Y1 - 2013

N2 - The aim of this study was to explore the antitumor effect of Gan-Lu-Yin (GLY), a traditional Chinese herbal formula, on leukemia. Ethanolic extract of GLY was applied to evaluate its regulatory mechanisms in proliferation, migration, and differentiation of WEHI-3 leukemic cells as well as antitumor effect on BALB/c mice model. The results showed that GLY markedly reduced cell proliferation and migration with induced differentiation of WEHI-3 cells. The expression level of phosphorylated FAK, Akt, ERK1/2, and Rb was decreased p21 expression while level was increased in WEHI-3 treated with GLY. The results of cell cycle analysis revealed that GLY treatment could markedly induce G1 phase arrest and decrease cell population in S phase. Moreover, experimental results demonstrated that GLY decreased the protein expression and enzyme activity of MMP-2 and MMP-9. GLY treatment also reduced WEHI-3 leukemic infiltration in liver and spleen and tumor growth in animal model. Accordingly, GLY demonstrated an inhibitory effect on tumor growth with a regulatory mechanism partially through inhibiting FAK, Akt, and ERK expression in WEHI-3 cells. GLY may provide a promising antileukemic approach in the clinical application.

AB - The aim of this study was to explore the antitumor effect of Gan-Lu-Yin (GLY), a traditional Chinese herbal formula, on leukemia. Ethanolic extract of GLY was applied to evaluate its regulatory mechanisms in proliferation, migration, and differentiation of WEHI-3 leukemic cells as well as antitumor effect on BALB/c mice model. The results showed that GLY markedly reduced cell proliferation and migration with induced differentiation of WEHI-3 cells. The expression level of phosphorylated FAK, Akt, ERK1/2, and Rb was decreased p21 expression while level was increased in WEHI-3 treated with GLY. The results of cell cycle analysis revealed that GLY treatment could markedly induce G1 phase arrest and decrease cell population in S phase. Moreover, experimental results demonstrated that GLY decreased the protein expression and enzyme activity of MMP-2 and MMP-9. GLY treatment also reduced WEHI-3 leukemic infiltration in liver and spleen and tumor growth in animal model. Accordingly, GLY demonstrated an inhibitory effect on tumor growth with a regulatory mechanism partially through inhibiting FAK, Akt, and ERK expression in WEHI-3 cells. GLY may provide a promising antileukemic approach in the clinical application.

UR - http://www.scopus.com/inward/record.url?scp=84876572607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876572607&partnerID=8YFLogxK

U2 - 10.1155/2013/684071

DO - 10.1155/2013/684071

M3 - Article

C2 - 23573143

AN - SCOPUS:84876572607

VL - 2013

JO - Evidence-based Complementary and Alternative Medicine

JF - Evidence-based Complementary and Alternative Medicine

SN - 1741-427X

M1 - 684071

ER -